Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6500
+0.0600 (3.77%)
NASDAQ · Last Trade: Dec 25th, 2:17 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Which stocks are moving after the closing bell on Wednesday?chartmill.com
As the regular session of the US market concludes on Wednesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Via Chartmill · December 24, 2025
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga.com
Via Benzinga · November 20, 2025
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga.com
Via Benzinga · August 18, 2025
These stocks are moving in today's pre-market sessionchartmill.com
Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via Chartmill · August 18, 2025
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · August 18, 2025
Inhibikase Posts Wider Loss in Q2fool.com
Via The Motley Fool · August 14, 2025
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · June 30, 2025
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · June 27, 2025
This PPG Industries Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesdaybenzinga.com
Via Benzinga · February 12, 2025
Stay updated with the stocks that are on the move in today's pre-market session.chartmill.com
Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top gainers and losers in today's pre-market session.
Via Chartmill · January 30, 2025
Curious about the stocks that are showing activity after the closing bell on Wednesday?chartmill.com
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via Chartmill · January 29, 2025
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga.com
Via Benzinga · November 8, 2024
This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Fridaybenzinga.com
Via Benzinga · November 8, 2024
Why Tesla Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · October 24, 2024
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga.com
Via Benzinga · October 14, 2024
Dow Surges 350 Points; US Crude Oil Stocks Increasebenzinga.com
Via Benzinga · October 9, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · October 9, 2024
Crude Oil Edges Lower; US Wholesale Inventories Rise 0.1% In Augustbenzinga.com
Via Benzinga · October 9, 2024
Why Inhibikase Therapeutics (IKT) Stock Is Up 50% Todaybenzinga.com
Inhibikase Therapeutics shares are trading higher by 50% during Wednesday's session. The company announced the pricing of an approximately $110 million private placement financing.
Via Benzinga · October 9, 2024
Dow Jumps Over 100 Points; Helen Of Troy Posts Upbeat Q2 Resultsbenzinga.com
Via Benzinga · October 9, 2024
IKT Stock Earnings: Inhibikase Therapeutics Beats EPS for Q2 2024investorplace.com
IKT stock results show that Inhibikase Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 14, 2024
IKT Stock Earnings: Inhibikase Therapeutics Beats EPS for Q1 2024investorplace.com
IKT stock results show that Inhibikase Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 16, 2024
Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Sessionbenzinga.com
Via Benzinga · April 22, 2024
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga.com
Via Benzinga · April 22, 2024
IKT Stock Earnings: Inhibikase Therapeutics Beats EPS for Q4 2023investorplace.com
IKT stock results show that Inhibikase Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.
Via InvestorPlace · March 27, 2024